Mfg Part Number
Ab00421-1.4
Vector Labs Ab00421-1.4 Anti-Type IV collagenase [3G11], Mouse IgG1, Fc Silent™, kappa (200 μg)
Quick Overview
The original antibody was generated by immunizing BALB/c mice with recombinant human type IV collagenase.
$517.40
Order will ship within 1-3 business days
| Product Class: | Purified |
|---|---|
| Clone ID: | 3G11 |
| Heavy Chain Modification: | Fc Silent™ |
| Synonyms: | MMP2; MMP-2; MMP 2; TBE-1; Matrix Metalloprotease 2; 72 kDa type IV collagenase; 72 kDa gelatinase; Gelatinase A |
| Amount: | 200 μg |
| Application Codes Clone: | ELISA; Immunoscintigraphy; MTT assay; IHC; IF; in vivo |
| Shipping Temperature: | Wet Ice |
| Origin Pub PMID: | 20303650 |
| Buffer Composition: | PBS with 0.02% Proclin 300. |
| Original Format: | IgG1 |
| Storage Temperature: | Store at 4⁰C for up to 3 months. For longer storage, aliquot and store at -20⁰C. |
| Specificity Statement: | This antibody binds specifically to human and mouse type IV collagenase and does not show any cross-reactivity with any other collagenases. Human type IV collagenase, a metalloproteinase involved in degrading matrix proteins and hence contributing largely to metastasis in various types of cancer. |
| Application Notes: | The specificity of the original format of this antibody (mouse IgG1, κ) was measured by ELISA analysis. The (131)I-labeled version of this antibody was demonstrated to be stable in vitro for almost 72 h. The blood clearance pattern of (125)I-labeled 3G11 was defined as a two-compartment model, with a 7.2 h T1/2α and a 345.2 h T1/2β. A clear scintigraphic image of human lung carcinoma PG was obtained using (131)I-labeled 3G11 at 72 h, which further improved at 120 h (Dai et al., 2003; PMID: 14693044). Lidamycin (LDM) was conjugated to the Fab version of this antibody, and the resulting immunoconjugate maintained most of its immunoreactivity to both type IV collagenase and mouse hepatoma 22 cells, as shown by ELISA, and exhibited more potent cytotoxicity to hepatoma 22 cells than free LDM by MTT assay. Furthermore, when administered intravenously, the Fab'-LDM conjugate was proven to be more effective against the growth of subcutaneously transplanted hepatoma 22 in mice than free LDM in two experiment settings, increasing mice survival time (Fengqiang et al., 2004; PMID: 15382678). The scFv version of this antibody was constructed and used in various configurations for IF and in vivo imaging and therapeutic applications (Zhong et al., 2010; PMID: 20303650) (Kong et al., 2015; PMID: 25824464). |
| Brand | Vector Labs |
|---|---|
| UNSPSC | 12161500 |